Apiam Animal Health Limited
Apiam Animal Health Limited Fundamental Analysis
Apiam Animal Health Limited (AHX.AX) shows weak financial fundamentals with a PE ratio of 192.48, profit margin of 0.40%, and ROE of 0.69%. The company generates $0.2B in annual revenue with weak year-over-year growth of 1.11%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 18.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze AHX.AX's fundamental strength across five key dimensions:
Efficiency Score
WeakAHX.AX struggles to generate sufficient returns from assets.
Valuation Score
ModerateAHX.AX shows balanced valuation metrics.
Growth Score
WeakAHX.AX faces weak or negative growth trends.
Financial Health Score
ModerateAHX.AX shows balanced financial health with some risks.
Profitability Score
ModerateAHX.AX maintains healthy but balanced margins.
Key Financial Metrics
Is AHX.AX Expensive or Cheap?
P/E Ratio
AHX.AX trades at 192.48 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, AHX.AX's PEG of -2.30 indicates potential undervaluation.
Price to Book
The market values Apiam Animal Health Limited at 1.32 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 2.81 times EBITDA. This is generally considered low.
How Well Does AHX.AX Make Money?
Net Profit Margin
For every $100 in sales, Apiam Animal Health Limited keeps $0.40 as profit after all expenses.
Operating Margin
Core operations generate 14.50 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.69 in profit for every $100 of shareholder equity.
ROA
Apiam Animal Health Limited generates $0.33 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Apiam Animal Health Limited generates limited operating cash flow of $18.11M, signaling weaker underlying cash strength.
Free Cash Flow
Apiam Animal Health Limited produces free cash flow of $12.06M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.06 in free cash annually.
FCF Yield
AHX.AX converts 7.15% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
192.48
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-2.30
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.32
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.79
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.85
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.95
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.007
vs 25 benchmark
ROA
Return on assets percentage
0.003
vs 25 benchmark
ROCE
Return on capital employed
0.14
vs 25 benchmark
How AHX.AX Stacks Against Its Sector Peers
| Metric | AHX.AX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 192.48 | 24.05 | Worse (Expensive) |
| ROE | 0.69% | 1163.00% | Weak |
| Net Margin | 0.40% | 785.00% | Weak |
| Debt/Equity | 0.85 | 0.77 | Neutral |
| Current Ratio | 0.95 | 2.40 | Weak Liquidity |
| ROA | 0.33% | -8308.00% (disorted) | Weak |
AHX.AX outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Apiam Animal Health Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
10.54%
Industry Style: Cyclical, Growth, Discretionary
High GrowthEPS CAGR
-87.39%
Industry Style: Cyclical, Growth, Discretionary
DecliningFCF CAGR
48.55%
Industry Style: Cyclical, Growth, Discretionary
High Growth